Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-16

FDA Approved: IRINOTECAN HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for irinotecan hydrochloride (Actavis Pharma, Inc.), approving changes to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)

Snippet

SUPPL AP for IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)